Severe vitamin D deficiency associated with BRAF-mutated melanoma

被引：4
|
作者：
Fearfield, L. [1 ]
Nobbs, J. [1 ]
Petruckevitch, A. [2 ]
Harland, C. [1 ]
机构：
[1] Royal Marsden Hosp, Dept Dermatol, Skin & Melanoma Unit, London, England
[2] Royal Marsden Hosp, Dept Stat, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 181卷 / 06期
关键词：
SURVIVAL;
D O I：
10.1111/bjd.18413
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1343 / 1343
页数：1
相关论文
共 50 条
  • [31] Cost-Effectiveness of Treatment Strategies for BRAF-Mutated Metastatic Melanoma
    Curl, Patti
    Vujic, Igor
    van 't Veer, Laura J.
    Ortiz-Urda, Susana
    Kahn, James G.
    [J]. PLOS ONE, 2014, 9 (09):
  • [32] BRAF-mutated malignant melanoma with chondrosarcomatous differentiation in inguinal nodal metastasis
    Abbati, Francesca
    Altimari, Annalisa
    Corti, Barbara
    Dika, Emi
    Sperandi, Francesca
    Melotti, Barbara
    [J]. CLINICAL CASE REPORTS, 2021, 9 (04): : 2200 - 2204
  • [33] Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma
    Kim, Hee Kyung
    Lee, Sunyoung
    Kim, Kyung
    Heo, Mi Hwa
    Lee, Hansang
    Cho, Jinhyun
    Kim, Nayoung K. D.
    Park, Woongyang
    Lee, Su Jin
    Kim, Jung Han
    Jang, Kee-Taek
    Choi, Sang-Hee
    Lee, Jeeyun
    [J]. TRANSLATIONAL ONCOLOGY, 2016, 9 (06): : 557 - 564
  • [34] Fulminant Disseminated Intravascular Coagulation as Initial Presentation of BRAF-Mutated Melanoma
    Chuang, Jeremy
    Uche, An
    Gupta, Rohan
    Margolin, Kim
    Kim, Phyllis
    [J]. CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
  • [35] Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma
    Kim, Jihoon
    Archer, Paul A.
    Manspeaker, Margaret P.
    Avecilla, Alexa R. C.
    Pollack, Brian P.
    Thomas, Susan N.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2023, 357 : 655 - 668
  • [36] Fisetin enhances the therapeutic efficacy of sorafenib in BRAF-mutated human melanoma
    Pal, H. C.
    Baxter, R. D.
    Agarwal, J.
    Strickland, L. R.
    Elmets, C. A.
    Afaq, F.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S127 - S127
  • [37] Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
    Long, G. V.
    Hauschild, A.
    Santinami, M.
    Atkinson, V.
    Mandala, M.
    Chiarion-Sileni, V.
    Larkin, J.
    Nyakas, M.
    Dutriaux, C.
    Haydon, A.
    Robert, C.
    Mortier, L.
    Schachter, J.
    Schadendorf, D.
    Lesimple, T.
    Plummer, R.
    Ji, R.
    Zhang, P.
    Mookerjee, B.
    Legos, J.
    Kefford, R.
    Dummer, R.
    Kirkwood, J. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19): : 1813 - 1823
  • [38] Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma
    Audrito, Valentina
    Manago, Antonella
    La Vecchia, Sofia
    Zamporlini, Federica
    Vitale, Nicoletta
    Baroni, Gianna
    Cignetto, Simona
    Serra, Sara
    Bologna, Cinzia
    Stingi, Aureliano
    Arruga, Francesca
    Vaisitti, Tiziana
    Massi, Daniela
    Mandala, Mario
    Raffaelli, Nadia
    Deaglio, Silvia
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (03)
  • [39] Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells
    Schrama, D.
    Zhu, G.
    Goebeler, M.
    Houben, R.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 : 26 - 27
  • [40] Combination with γ-secretase inhibitor prolongs treatment efficacy of BRAF inhibitor in BRAF-mutated melanoma cells
    Zhu, Guannan
    Yi, Xiuli
    Haferkamp, Sebastian
    Hesbacher, Sonja
    Li, Chunying
    Goebeler, Matthias
    Gao, Tianwen
    Houben, Roland
    Schrama, David
    [J]. CANCER LETTERS, 2016, 376 (01) : 43 - 52
12345